The potential for mRNA application in human health is huge. Nowadays, mRNA is widely employed as a popular vaccine technique in the prevention and treatment of a wide range of infectious and non-infectious disorders. Two RNA vaccine platforms are available: conventional mRNA encoding only the protein of interest and self-amplifying RNA (saRNA) that encodes both the protein of interest and replicase derived from specific virus strains. The replicase is composed of nonstructural proteins (nsP1-nsP4) that are encoded by replicons. As the key component, it enables the self-replication of a saRNA molecule and leads to high expression levels of proteins at low doses. Upon delivery, the replicase can generate numerous copies of saRNA followed by the production of a large amount of the target protein as shown in Fig 1.
Fig 1 The production of proteins using mRNA and saRNA.1
The main advantages of saRNA include:
Creative Biolabs provides two designs for RNA self-amplification:
Fig 2 Comparison of saRNA and taRNA.1
Creative Biolabs provides one-stop saRNA synthesis services. You only need to provide the gene name or sequence, and we will perform codon optimization, sequence design, gene synthesis, and subsequent mRNA synthesis and purification. Throughout the entire process from product design to delivery, professionals provide one-on-one timely communication to ensure that the mRNA is synthesized efficiently and quickly while meeting your needs. We can also provide design and optimization suggestions for specific applications based on customer needs, including optimized design of 5'UTR and 3'UTR, optimized design of poly A tail, and codon optimization tools. Modification of mRNA molecules to improve the activity of specific applications, according to different customers have different needs for mRNA projects, and provide a variety of purification processes to choose from, including column purification, Oligo dT purification, and dsRNA removal; rich QC options to meet the research needs of each stage. Please get in touch with us in time to learn more about saRNA.
Reference